Plain-English translation of NCT07428616 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to treat meningioma โ a type of brain tumor โ that has come back or gotten worse despite previous surgery or radiation. The study will enroll about 100 people with this condition to see whether the medication is safe and whether it can slow or stop tumor growth.
Meningiomas that return or continue growing after standard treatments like surgery and radiation are very difficult to manage, and patients need new options. This medication may work by blocking signals that help tumors grow, offering hope for people who have run out of other treatment choices.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would take this medication by mouth once every day. The study team will monitor you with regular check-ins, blood tests, and imaging scans to see how you're responding and to watch for any side effects. Most of the details about how long you'll be in the study and how often you'll visit the clinic will be explained by the research team when you join.
AI-generated summary from trial data ยท Oct 3, 2026 ยท Not medical advice
United States